Is Pancreatic Cancer Curable?

2 Answers

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
Besides swelling of the left hand, what other symptoms are their for pancreatic cancer?
common symptoms of pancreatic adenocarcinoma occurring before diagnosis include:

Pain in the upper abdomen or back, often spreading from around the stomach to the back. The location of the pain can indicate the part of the pancreas where a tumor is located. The pain may be worse at night and may increase over time to become severe and unremitting. It may be slightly relieved by bending forward. In the UK, about half of new cases of pancreatic cancer are diagnosed following a visit to a hospital emergency department for pain or jaundice. In up to two-thirds of people abdominal pain is the main symptom, for 46% of the total accompanied by jaundice, with 13% having jaundice without pain.
Jaundice, a yellow tint to the whites of the eyes or skin, with or without pain, and possibly in combination with darkened urine. This results when a cancer in the head of the pancreas obstructs the common bile duct as it runs through the pancreas.[30]
Unexplained weight loss, either from loss of appetite, or loss of exocrine function resulting in poor digestion.
The tumor may compress neighboring organs, disrupting digestive processes and making it difficult for the stomach to empty, which may cause nausea and a feeling of fullness. The undigested fat leads to foul-smelling, fatty feces that are difficult to flush away.Constipation is common.
At least 50% of people with pancreatic adenocarcinoma have diabetes at the time of diagnosis. While long-standing diabetes is a known risk factor for pancreatic cancer (see Risk factors), the cancer can itself cause diabetes, in which case recent onset of diabetes could be considered an early sign of the disease.
You didn't answer the question is it curable
It's not, even found in an very early stage the 5-year survival is very low, close to 30%.
Good news!

University of Pennsylvania researchers are reporting early but encouraging results from two small ongoing studies of experimental treatments for metastatic pancreatic cancer.

One study combined two standard chemotherapies with varying doses of an experimental antibody, called APX005M.

The other study enrolled patients with a mutation in BRCA1, BRCA2 or PALB2 genes. These defects, carried by about 6 percent of pancreatic cancer patients, are known to increase the chance of developing the disease, as well as breast and ovarian cancer.

The study switched the patients from chemotherapy to Rubraca, a "PARP inhibitor" drug approved a year ago as a maintenance therapy for advanced ovarian cancer patients.

Many participants of the two studies have seen the tumor shrink.

Scientists say it's very preliminary but exciting.